Tocqueville Asset Management L.P. Biomarin Pharmaceutical Inc Transaction History

Tocqueville Asset Management L.P.

$6.27 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$83.81 - $99.0 $8.38 Million - $9.9 Million	-100,000 Reduced 97.37%	2,700 $235,000
Q4 2023 Feb 12, 2024	SELL	$76.22 - $98.51 $2.03 Million - $2.63 Million	-26,665 Reduced 20.61%	102,700 $9.9 Million
Q3 2023 Nov 09, 2023	BUY	$85.07 - $94.48 $1.56 Million - $1.73 Million	18,290 Added 16.47%	129,365 $11.4 Million
Q2 2023 Aug 11, 2023	SELL	$86.68 - $100.3 $1.47 Million - $1.7 Million	-16,945 Reduced 13.24%	111,075 $9.63 Million
Q1 2023 May 10, 2023	SELL	$87.74 - $117.27 $2,632 - $3,518	-30 Reduced 0.02%	128,020 $12.4 Million
Q4 2022 Feb 09, 2023	SELL	$80.93 - $108.63 $2,832 - $3,802	-35 Reduced 0.03%	128,050 $13.3 Million
Q3 2022 Nov 10, 2022	SELL	$82.16 - $96.94 $98,592 - $116,328	-1,200 Reduced 0.93%	128,085 $10.9 Million
Q2 2022 Aug 12, 2022	BUY	$71.48 - $86.85 $61,472 - $74,691	860 Added 0.67%	129,285 $10.7 Million
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $2.32 Million - $2.9 Million	-31,267 Reduced 19.58%	128,425 $9.9 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $6.48 Million - $8.27 Million	-90,360 Reduced 36.14%	159,692 $14.1 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $221,842 - $253,589	2,967 Added 1.2%	250,052 $19.3 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $841,030 - $944,391	11,138 Added 4.72%	247,085 $20.6 Million
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $246,011 - $298,551	3,292 Added 1.41%	235,947 $17.8 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $518,072 - $643,577	7,135 Added 3.16%	232,655 $20.4 Million
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $16.2 Million - $29.5 Million	225,520 New	225,520 $17.2 Million
Q2 2019 Jul 31, 2019	SELL	$80.35 - $93.9 $6.89 Million - $8.05 Million	-85,725 Closed	0 $0
Q1 2019 Apr 30, 2019	BUY	$84.2 - $98.62 $3,031 - $3,550	36 Added 0.04%	85,725 $7.62 Million
Q4 2018 Feb 08, 2019	BUY	$80.14 - $106.07 $17,550 - $23,229	219 Added 0.26%	85,689 $7.3 Million
Q3 2018 Nov 13, 2018	BUY	$93.92 - $105.72 $97,207 - $109,420	1,035 Added 1.23%	85,470 $8.29 Million
Q2 2018 Aug 13, 2018	SELL	$76.01 - $99.03 $155,820 - $203,011	-2,050 Reduced 2.37%	84,435 $7.95 Million
Q1 2018 May 14, 2018	BUY	$77.67 - $92.63 $6.72 Million - $8.01 Million	86,485 New	86,485 $7.01 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.

Account